RARE News

Pomerantz LLP Advises Shareholders of Class Action Filing Against Ultragenyx Pharmaceutical Inc. – RARE

RARE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Alerts Shareholders to Investor Suit Against Ultragenyx Pharmaceutical Inc. – RARE

Pomerantz LLP Advises Shareholders of Class Action Against Ultragenyx Pharmaceutical Inc. – RARE

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Pomerantz LLP Advises Shareholders of Class Action Involving Ultragenyx Pharmaceutical Inc. - RARE

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm